Prostamax

Price range: $52.00 through $99.00

  • Contents: Prostamax (Lys-Glu-Asp-Pro; KEDP tetrapeptide)
  • Form: Lyophilized powder
  • Purity: >99%
Quantity Discount Price
1 - 3 - -
4 - 7 10% -
8 + 18% -
SKU: N/A Category:

Description

Prostamax is a synthetic tetrapeptide bioregulator with the sequence Lys-Glu-Asp-Pro (KEDP), developed by Professor Vladimir Khavinson from prostate tissue extract. It is the prostate-targeted member of the Khavinson bioregulator series. Like other bioregulators in this class, Prostamax enters cell nuclei and modulates gene expression through direct peptide-DNA interaction. Its primary research context is prostatic tissue biology — chromatin decondensation in prostate cells, androgen receptor signaling pathways, and inflammatory gene regulation in glandular tissue models. A secondary research finding places it in lymphocyte chromatin biology, documented by Meskhi et al. in a specialty research peptide context that parallels Livagen’s dual-tissue profile.

Key Characteristics

  • Prostate-specific tissue targeting within the Khavinson series. This specificity makes Prostamax the appropriate tool when the research question requires prostate gland biology rather than adjacent urogenital or endocrine tissue models
  • Zinc-binding properties connect Prostamax to zinc-dependent enzymatic function in prostatic tissue. Zinc is highly concentrated in the prostate gland and plays a documented role in prostatic metabolic regulation; Prostamax’s zinc-binding chemistry adds a mechanistic dimension specific to this tissue that distinguishes it from other Khavinson bioregulators
  • Androgen receptor signaling pathway modulation has been studied in aged prostate tissue models. This connects Prostamax to a well-characterized area of prostate biology research and separates it from compounds that operate purely through chromatin remodeling without documented interaction with hormonal signaling pathways
  • Lymphocyte chromatin effects — like several other Khavinson bioregulators, Prostamax’s intranuclear mechanism extends beyond its primary tissue target; unlike Thymosin Alpha 1, which engages lymphocyte biology through TLR pathway activation, Prostamax’s lymphocyte effects operate through the same chromatin decondensation mechanism as its prostate tissue activity
  • All published evidence is preclinical and concentrated within the Khavinson research network; chronic aseptic prostatitis rodent models represent the primary in vivo research context

Handling and Storage

Store as lyophilized powder under refrigeration, away from heat, moisture, and light. As a tetrapeptide, Prostamax is susceptible to proteolytic degradation under suboptimal conditions. Reconstitute immediately before use and avoid repeated freeze-thaw cycles.

FAQs

What is Prostamax?

Prostamax (KEDP) is a synthetic tetrapeptide bioregulator from the Khavinson series, derived from prostate tissue extract. It targets prostatic epithelial and stromal cell nuclei through direct peptide-DNA interaction, modulating chromatin structure and gene expression in prostate tissue models. Its documented research contexts include androgen receptor signaling, zinc-dependent prostatic enzyme regulation, and inflammatory pathway gene regulation. All evidence is preclinical.

What makes Prostamax unique within the Khavinson bioregulator series?

It is the only prostate-targeted bioregulator in the series. Most Khavinson bioregulators target neural, cardiac, immune, or hepatic tissues. Prostamax specifically addresses prostatic epithelial and stromal cell biology — including the zinc-binding chemistry and androgen receptor pathway context that are specific to prostate tissue physiology. Its zinc-binding property has no equivalent in other Khavinson compounds in this catalog.

How does Prostamax’s lymphocyte activity differ from Thymosin Alpha 1?

Both have documented activity in lymphocyte populations, but through entirely different mechanisms. Thymosin Alpha 1 activates lymphocyte-associated Toll-like receptor pathways on dendritic cells and immune cell populations — a receptor-mediated immune signaling mechanism. Prostamax induces chromatin decondensation in lymphocytes through the same intranuclear peptide-DNA interaction that drives its prostate tissue effects. Researchers studying immune cell chromatin biology use Prostamax; those studying innate immune receptor signaling use Thymosin Alpha 1.